Top 4 Stocks In The Biotechnology Industry With The Highest Revenue

Below are the biotechnology stocks on the NYSE and the NASDAQ in terms of revenue.

The trailing-twelve-month revenue at Amgen (NASDAQ: AMGN) is $19.46 billion. Amgen's profit margin for the same period is 25.74%.

The trailing-twelve-month revenue at Gilead Sciences (NASDAQ: GILD) is $17.44 billion. Gilead Sciences' ROE for the same period is 53.55%.

The trailing-twelve-month revenue at Biogen Idec (NASDAQ: BIIB) is $8.34 billion. Biogen Idec's EPS for the same period is $8.04.

The trailing-twelve-month revenue at Celgene (NASDAQ: CELG) is $7.03 billion. Celgene's PEG ratio is 0.89.